Faron Pharmaceuticals Oy received a notification of major holdings from Markku Jalkanen and Sirpa Jalkanen. The reason for the notification was a change due to the Share Offering. The threshold was crossed on 20th June 2024, and the total positions of the persons subject to the notification obligation were detailed. The resulting situation on the date the threshold was crossed or reached showed a 3.26% voting rights attached to shares, totaling 3,413,434 voting rights held in the issuer.
The notification also included details of financial instruments, with a breakdown of voting rights and information about the person subject to the notification obligation. The notification confirmed that the person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer.
Additionally, the notification mentioned the Faron Share Offering on 20th June 2024, with the place of completion being Turku, Finland. The date of completion was also provided in the notification.